Financial insights of MDT

MyFinsight

Income Statement	2026-04-24	2025-04-25	2024-04-26	2023-04-28
Net sales	36,364	33,537	32,364	31,227
Cost of products sold, excluding amortization of intangible assets	12,721	11,632	11,216	10,719
Research and development expense	2,873	2,732	2,735	2,696
Selling, general, and administrative expense	11,784	10,849	10,736	10,415
Amortization of intangible assets	1,772	1,807	1,693	1,698
Restructuring charges, net	249	267	226	375
Certain litigation charges, net	113	317	149	-30
Other operating expense (income), net	-386	23	-464	131
Operating profit	6,467	5,955	5,144	5,485
Other non-operating expense (income), net	384	402	412	515
Interest expense, net	715	729	719	636
Income before income taxes	6,136	5,628	4,837	5,364
Income tax provision	1,299	936	1,133	1,580
Net income	4,837	4,691	3,705	3,784
Net income attributable to noncontrolling interests	37	29	28	26
Net income attributable to medtronic	4,801	4,662	3,676	3,758

Basic EPS	3.75	3.63	2.77	2.83
Diluted EPS	3.73	3.61	2.76	2.82
Basic Average Shares	1,281,800,000	1,285,600,000	1,327,700,000	1,329,800,000
Diluted Average Shares	1,288,100,000	1,289,900,000	1,330,200,000	1,332,800,000

Unit: Million (M) dollars (except for numbers of shares and EPS).